Colofac MR Capsules 200mg

Colofac MR 200 mg is a modified-release capsule containing 200 mg of mebeverine hydrochloride, an antispasmodic medicine used to treat the symptoms of irritable bowel syndrome (IBS) and certain other gut conditions associated with painful spasm of the bowel wall. The "MR" stands for modified release — the capsule is designed to deliver mebeverine slowly and steadily across the day rather than all at once, which is why it's taken twice daily rather than three times. It eases cramping abdominal pain, reduces spasm-related bloating, and helps the gut settle into a more comfortable rhythm, particularly around meals.

This is the most useful question to answer first, because once you understand the formulation, several other things fall into place. A regular immediate-release tablet — like the Colofac 135 mg — dissolves quickly once swallowed, releases its mebeverine within an hour or so, and produces a peak in blood levels followed by a gradual decline. That's why immediate-release Colofac is taken three times a day: the medicine wears off after a few hours and a fresh dose is needed before each meal. A modified-release capsule, by contrast, contains hundreds of tiny granules with a special coating that dissolves at different rates inside the gut. The result is that mebeverine is released gradually over many hours rather than in a single burst, producing steadier blood levels with smaller peaks and troughs. That's why Colofac MR can be taken twice a day rather than three times — each capsule's "long tail" of release keeps the medicine working between doses. The active ingredient is identical in both forms; only the delivery system differs.

The two work equally well at treating IBS spasm — neither is medically superior. The choice usually comes down to lifestyle and convenience rather than effectiveness. Colofac 135 mg three times daily fits naturally if you have three regular meals at predictable times and don't mind taking a tablet before each. Colofac MR 200 mg twice daily works better for people whose schedules don't accommodate three doses, who tend to forget midday medication, who work irregular shifts, or who simply find twice-daily dosing easier to remember. There's also some evidence that steady-state blood levels — the kind MR formulations produce — provide more consistent symptom control across the day, although the difference is modest. If you've been on the immediate-release form and find yourself missing the midday dose, asking about a switch to Colofac MR is a reasonable conversation to have.

This is worth a moment, because once you understand the mechanism, much of the rest follows naturally. The walls of the intestine contain a thin layer of smooth muscle that contracts in coordinated waves to move food and waste through the digestive system. In IBS, those contractions become exaggerated, irregular, and painful — the gut wall goes into spasm rather than producing gentle, rhythmic waves. Mebeverine works directly on that smooth muscle, persuading it to relax. What's interesting about it is that it eases the spasmodic contractions specifically without switching off the normal background motility of the gut, so you get pain relief without becoming bloated or constipated. Picture the difference between a clenched fist and a hand at rest — mebeverine helps the gut wall settle back into the resting state without forcing the whole arm to stop moving.

The standard adult regimen is one capsule (200 mg) twice a day, taken about 20 minutes before breakfast and 20 minutes before the evening meal. Swallow the capsule whole with a glass of water — and this is important — do not crush, chew, open, or break the capsule. The reason is the modified-release technology. Each capsule contains tiny granules with a special coating that dissolves at different rates inside the gut, releasing mebeverine gradually over many hours. If you break the capsule open or chew it, you destroy that coating, all 200 mg of mebeverine releases at once, and you end up with a single high peak followed by no medicine in your system for the rest of the day — exactly the opposite of what the formulation is designed to achieve. The same applies to other MR medicines you may come across; "do not crush" warnings on prescription labels carry weight. If you find capsules difficult to swallow, mention it to your prescriber rather than trying to break them open; they can switch you to the immediate-release tablet, which can be split or crushed if absolutely necessary.

This is one of the things people often get wrong, and it matters for both Colofac 135 mg and Colofac MR. IBS pain is often triggered by eating, because food entering the gut activates the gastrocolic reflex — a normal reflex that ramps up gut motility after meals. In someone with IBS, that ramp-up is exaggerated and tips the gut into spasm. Taking Colofac MR 20 minutes before a meal allows the medicine to start being absorbed and reaching the gut muscle just as the food is arriving, blunting the spasm before it can build. Taking the capsule with food or after meals delays absorption and reduces how well it manages post-meal cramping — the most common IBS symptom. Setting a phone reminder for 20 minutes before mealtimes is a small habit that pays off.

Some people feel a useful effect within the first few days, particularly on post-meal cramping. Others notice change more gradually over two to four weeks of regular use. Colofac MR isn't a painkiller in the conventional sense — it doesn't dull pain like paracetamol or ibuprofen — and it works best when the gut is being exposed to it consistently, twice a day, day after day. A fair trial of Colofac MR therefore means taking it consistently for at least three to four weeks before deciding whether it's helping. If you've been taking it irregularly, that may be why it doesn't seem to be making much difference yet.

Yes, in most cases. Colofac MR is generally considered safe for long-term use because mebeverine doesn't accumulate in the body, doesn't have anticholinergic side effects, and isn't habit-forming. Many people take it for months or years through periods when their IBS is active, then taper off during quieter spells, then return to it during flares. Others take it continuously as a stable daily routine. There's no rebound or withdrawal when you stop, although some people find that symptoms return — which reflects the underlying IBS rather than the medicine itself. A periodic review with your prescriber — perhaps every six to twelve months — is a sensible habit, both to check that the treatment is still working and to discuss whether other measures (diet, lifestyle, additional medicines) could add further benefit.

Colofac MR is among the better-tolerated IBS medicines, which is much of its appeal. Most people experience no side effects at all. When effects do occur, they're typically mild and infrequent — the main reported issue is occasional skin reactions, including rash, hives (urticaria), or very rarely more significant hypersensitivity reactions with swelling of the face, lips, or throat (angioedema). Stopping the medicine and seeking medical advice is the right response to any of these. Beyond that, mebeverine genuinely doesn't have the dry-mouth, blurred-vision, drowsiness, or urinary retention effects that older antispasmodics produce, which is why it's well tolerated in older patients and those on multiple medications.

No. Mebeverine has no habit-forming or dependence-producing properties. It works on smooth muscle in the gut, not on the brain's reward or stress pathways, so there's no craving when you stop and no tolerance that develops over time. Some patients worry they've become "dependent" on Colofac because symptoms return when they stop taking it — but that's the underlying IBS reasserting itself, not the medicine producing dependence.

Alcohol doesn't directly interact with mebeverine in the way it interacts with some other medicines — a glass of wine or a beer is unlikely to cause a problem from the medicine itself. The wider issue is that alcohol is a recognised IBS trigger for many people. It can speed gut transit, irritate the gut lining, and disturb the gut microbiome, all of which can flare IBS symptoms regardless of which medicine you're taking. So while there's no strict medical reason to abstain, paying attention to whether alcohol seems to bring your symptoms back, and moderating accordingly, is part of sensible IBS management.

The safety data in pregnancy is genuinely limited, and the manufacturer recommends caution. Most clinicians prefer to avoid Colofac MR during pregnancy unless it's clearly needed and other measures haven't worked, both because data is sparse and because IBS symptoms in pregnancy can often be managed with dietary adjustment, fibre changes, and reassurance. Breastfeeding sits in a similar grey zone — small amounts may pass into breast milk, and again, alternative approaches are usually preferred. If you're pregnant, planning a pregnancy, or breastfeeding and your IBS symptoms are significant, it's worth a direct conversation with your GP rather than self-managing — there are options that are better studied in these settings.

This is one of mebeverine's quieter advantages: it has very few clinically significant drug interactions. It doesn't meaningfully affect blood thinners, blood pressure medicines, antidepressants, hormonal contraceptives, or most other commonly prescribed drugs. That makes it a good choice for older patients on multiple medications and for anyone with a complex prescription list. As always, it's still worth telling any prescriber that you're taking it, particularly when starting new medicines.

For most people, no — and this is where IBS care has changed significantly in the last decade. The evidence is now strong that dietary and lifestyle measures play at least as big a role as medication in long-term IBS control. The most effective dietary approach for many people is the low-FODMAP diet, a structured elimination and reintroduction of certain fermentable carbohydrates that ferment in the gut and produce gas, distension, and loose stool in IBS-prone individuals — ideally guided by a dietitian, because done badly it can become unnecessarily restrictive. Beyond diet, regular exercise, adequate hydration, attention to sleep, stress management, and — for some people — gut-directed psychological therapies such as cognitive behavioural therapy or hypnotherapy have all been shown to make meaningful differences. Colofac MR is a useful tool for the painful, spasmodic dimension of IBS, but it sits within a broader plan rather than instead of one.

Several alternatives exist, and one approach often works where another doesn't. Buscopan (hyoscine butylbromide) works through a different mechanism — blocking the nerve signal that tells the gut muscle to contract — and gives faster acute relief during flares. Peppermint oil capsules (Colpermin, Mintec) have a small but real evidence base for IBS pain, using menthol's effect on smooth muscle calcium channels. Alverine citrate (Spasmonal) is another smooth muscle antispasmodic with a similar profile to mebeverine. For diarrhoea-predominant IBS, loperamide helps slow gut transit. For constipation-predominant IBS, fibre adjustments, isphagula husk (Fybogel), or specific laxatives may be more useful — and the combined product Fybogel Mebeverine exists precisely for those who need both effects. Low-dose tricyclic antidepressants (such as amitriptyline) and SSRIs are sometimes used not for depression but for their effect on gut-brain signalling and visceral pain, and can be transformative for people with persistent IBS pain. If Colofac MR alone hasn't helped after a fair trial, the next step is usually to broaden the approach in conversation with a clinician rather than just keep waiting.

A few situations call for prompt medical review rather than self-management — and they matter, because IBS is what's known as a diagnosis of exclusion, meaning other conditions need to be ruled out first. The features that warrant urgent assessment, often called "red flags", include unintentional weight loss, rectal bleeding or blood in the stool, persistent diarrhoea (especially at night, which IBS doesn't typically cause), iron-deficiency anaemia, a family history of bowel or ovarian cancer, new bowel symptoms starting after age 50, an abdominal or rectal mass, and any markedly worsening symptoms. None of these features fits IBS, and they need investigation to exclude inflammatory bowel disease (Crohn's, ulcerative colitis), coeliac disease, and bowel cancer. Beyond the red flags, a clinical review is also worthwhile if symptoms aren't responding to standard measures, if they're significantly affecting your quality of life, work, or sleep, or if you've never had a formal diagnosis and want one.